TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 156 filers reported holding TURNING POINT THERAPEUTICS I in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $31,287,144 | +216.0% | 415,776 | +12.7% | 0.01% | +300.0% |
Q1 2022 | $9,901,824 | -38.0% | 368,783 | +10.2% | 0.00% | -33.3% |
Q4 2021 | $15,969,000 | -28.2% | 334,783 | 0.0% | 0.00% | -40.0% |
Q3 2021 | $22,240,000 | -16.4% | 334,783 | -1.8% | 0.01% | -16.7% |
Q2 2021 | $26,601,000 | -15.4% | 340,954 | +2.6% | 0.01% | -14.3% |
Q1 2021 | $31,435,000 | -35.1% | 332,330 | -16.4% | 0.01% | -36.4% |
Q4 2020 | $48,462,000 | +66.2% | 397,718 | +19.2% | 0.01% | +37.5% |
Q3 2020 | $29,155,000 | +60.6% | 333,736 | +18.7% | 0.01% | +60.0% |
Q2 2020 | $18,159,000 | +57.0% | 281,141 | +8.6% | 0.01% | +25.0% |
Q1 2020 | $11,564,000 | – | 258,940 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 308,686 | $13,786,000 | 8.42% |
Cormorant Asset Management, LP | 3,056,797 | $136,517,000 | 6.34% |
venBio Partners LLC | 160,333 | $7,160,000 | 6.10% |
Burrage Capital Management LLC | 77,172 | $3,250,000 | 3.20% |
Orbimed Advisors | 2,745,327 | $122,606,000 | 2.06% |
Parkman Healthcare Partners LLC | 80,318 | $3,587,000 | 1.66% |
SECTORAL ASSET MANAGEMENT INC | 117,800 | $5,261,000 | 1.01% |
DAFNA Capital Management LLC | 46,908 | $2,095,000 | 0.87% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $1,542,000 | 0.70% |
Nicholas Investment Partners, LP | 75,487 | $3,371,000 | 0.66% |